Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.
On November 12, 2024, a significant violation of Article 28 of the Food Safety and Sanitation Management Act was detected concerning the product known as "The Strongest Metabolic Enzyme Capsule." This incident was reported by the Taiwan Food and Drug Administration (FDA), highlighting the importance of adherence to food safety regulations within the industry.
The violation pertains to control measures that ensure the safety and quality of food products. Article 28 of the Food Safety and Sanitation Management Act outlines the necessary standards and practices that must be followed to protect consumer health and maintain the integrity of food products in the market. The identification of this violation raises concerns regarding compliance within the sector.
As a result of this incident, the Taiwan FDA is taking the necessary steps to address the violation and ensure that appropriate actions are implemented to rectify the situation. The agency's commitment to enforcing food safety regulations is crucial in maintaining public trust and safeguarding the health of consumers.
This case underscores the ongoing need for vigilance in food safety practices and the role of regulatory bodies in monitoring compliance. The incident serves as a reminder of the critical importance of adhering to established food safety regulations to prevent potential risks associated with food products.
- Incident: Violation of article 28 of the food safety and sanitation management act has been detected in The strongest metabolic enzyme capsule.
- Date: 2024-11-12
- Product: The strongest metabolic enzyme capsule
- Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Incident Category: Control
- Hazard Category: null
- Source: Taiwan Food and Drug Administration (FDA)
For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software.
Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)
